Badanie nad bezpieczeństwem i skutecznością AMB-05X u pacjentów z guzem olbrzymiokomórkowym błony maziowej ścięgna

The study focuses on a condition called Tenosynovial Giant Cell Tumor (TGCT), which is a type of tumor that affects the joints. The treatment being tested is a medication known as AMB-05X, which is given as an injection directly into the joint. The purpose of the study is to evaluate how safe and effective this treatment is for people with TGCT.

The study is divided into two parts. In the first part, participants will receive the AMB-05X injections over a period of 24 weeks. The second part involves extended treatment or observation to gather more information about the long-term effects of the medication. Throughout the study, researchers will monitor the participants to see how well the treatment works and to check for any side effects.

Participants in the study will undergo regular assessments, including imaging tests like MRI scans, to measure the size of the tumor and evaluate the response to the treatment. The study aims to determine the best dose of AMB-05X and to understand its impact on joint function and overall well-being of the participants. The study will also collect data on how the body processes the medication, known as pharmacokinetics.